Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.
about
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.No Association of Proton Pump Inhibitor Use with Fasting or Postload Glycaemia in Patients with Cardiovascular Disease: A Cross-Sectional Retrospective Study.Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.
P2860
Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Asymmetric Dimethylarginine ve ...... ease: A Cross-Sectional Study.
@en
type
label
Asymmetric Dimethylarginine ve ...... ease: A Cross-Sectional Study.
@en
prefLabel
Asymmetric Dimethylarginine ve ...... ease: A Cross-Sectional Study.
@en
P2093
P2860
P356
P1476
Asymmetric Dimethylarginine ve ...... sease: A Cross-Sectional Study
@en
P2093
Andrzej Surdacki
Bernadeta Chyrchel
Jacek Bednarek
Jadwiga Nessler
Jolanta Świerszcz
P2860
P356
10.3390/IJMS17040454
P407
P577
2016-04-15T00:00:00Z